IO2 INTERVENTIONAL & IMMUNO-ONCOLOGY

WIPO WIPO 2018

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die Internationale Marke IO2 INTERVENTIONAL & IMMUNO-ONCOLOGY wurde als Bildmarke am 24.10.2018 bei der Weltorganisation für geistiges Eigentum angemeldet.

Logodesign (Wiener Klassifikation)

#Quadrilateralen #Briefe, die eine besondere Form des Schreibens darstellen #Zahlen, die eine besondere Form der Schrift darstellen #Andere unregelmäßige Parallelogramme, Trapezien und Vierecke, Vierecke mit einer oder mehreren abgerundeten Ecken #Ein Viereck #Vierecke mit einer oder mehreren Ziffern #Quadrilaterale, die einen oder mehrere Buchstaben enthalten #Quadrilaterale mit dunklen Flächen oder Teilen von Flächen #Serie von Briefen, die verschiedene Formen des Schreibens darstellen #Zahlen, die einem Buchstaben oder einem Bildelement gegenübergestellt oder mit diesem verbunden sind

Markendetails Letztes Update: 23. Dezember 2021

Markenform Bildmarke
Aktenzeichen 1440678
Länder Europäische Gemeinschaft
Basismarke GB Nr. UK00003324486, 13. Juli 2018
Anmeldedatum 24. Oktober 2018
Ablaufdatum 24. Oktober 2028

Markeninhaber

5 Fleet Place
London EC4M 7RD
GB

Markenvertreter

Seventh Floor Offices Artillery House GB

Waren und Dienstleistungen

05 Pharmaceutical preparations for the treatment of cancer; preparations and substances for facilitating the delivery of pharmaceutical and medicinal preparations and substances; pharmaceutical preparations and substances for use in the circulatory system; pharmaceutical preparations and substances for embolization; pharmaceutical preparations and substances for embolization of tumours and arteriovenous malformations (AVMs); pharmaceutical preparations and substances for use in the circulatory system for the treatment of tumours and AVMs; adjuvants for medicinal purposes, vaccine adjuvants and vaccine preparations containing adjuvant; chemical reagents for medical purposes; transarterial chemoembolization pharmaceutical preparations, vaccines and sera; irradiated or radioactive microspheres used for in vivo therapeutic medical purposes; radiotherapy substances for medical purposes; radiopharmaceuticals; therapeutic agents for delivery of radioactive material to target sites within the body; beads, including microscopic radioactive beads, for treatment of cancerous tumours; beads, including microscopic glass beads, incorporating radioactive material for treatment of cancerous tumours; beads, radioactive glass beads; pharmaceutical preparations for use in chemotherapy
10 Surgical and medical apparatus and instruments; drug delivery embolisation apparatus, instruments and systems; apparatus and instruments for embolisation; surgical and medical apparatus and instruments, namely, catheters, injection syringes and sealed vial devices for dispensing microspheres during embolisation procedures in blood vessels and in the circulatory system; embolisation apparatus, instruments and systems comprising surgical and medical instruments for embolisation; drug delivery embolisation systems; drug delivery apparatus and instruments comprised of injection syringes, and sealed vials; injection syringes for use with catheters; apparatus and instruments for use in the circulatory system, namely, catheters, injection syringes and sealed vials; medical apparatus and instruments for embolisation; surgical and medical apparatus and instruments for embolisation, namely, embolisation apparatus, instruments and systems comprising microspheres and injection syringes for use in blood vessels and the circulatory system to carry out embolisation; radiotherapy apparatus; surgical and medical apparatus and instruments for delivery of radiopharmaceuticals and radioactive material to target sites within the body; beads, including microscopic glass beads, incorporating radioactive material or containing radioactive material and administered surgically for treatment of cancerous tumours; radioactive beads, including radioactive glass beads administered for treatment of cancerous tumours; surgical and medical apparatus and instruments for use in the circulatory system; needles for medical use, namely, cannula needles; medical devices for performing cryotherapy, namely, cryosurgical probes and cryoablation needles used for the minimally invasive cryoablation of cancerous tissues; medical apparatus consisting of treatment probes and high pressure valves used for heat or freeze treatment; surgical, medical and diagnostic materials, devices, apparatus and instruments for use in cryoablation, and the treatment of prostate cancer, kidney or renal tumours, and BPH; medical devices used to deliver heat to target sites using electrical current through needles; medical devices to deliver cryogen gas for freezing and either cryogen gas or electrical current for heating; medical devices for ablating human and animal tissue using microwave energy; medical devices for treating cancerous and benign tissue using microwave energy; parts and fittings for all of the aforesaid goods
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

Markenhistorie

Datum Belegnummer Bereich Eintrag
16. Juli 2019 2019/31 Gaz EM RAW: Rule 18ter(2)(ii) GP following a provisional refusal
09. Januar 2019 2019/3 Gaz EM Ablehnung
24. Oktober 2018 2018/50 Gaz GB Eintragung

ID: 141440678